Montana Molecular’s breakthroughs in cell based assay technologies have been made possible in part by continued support from the Montana Board of Research and Commercialization. The proposal entitled, “An Integrated Platform for Cell-Based Drug Discovery” was completed in December 2011. The objective of this project was to demonstrate that FRET biosensors developed by Montana Molecular could be adapted and optimized for fluorescence lifetime measurement.
